1. Lewandowski K. Contributions to the epidemiology of acute respiratory failure. Crit Care. 2003;7:288–290.
2. Luhr OR, Antonsen K, Karlsson M, et al. Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. Am J Respir Crit Care Med. 1999;159:1849–1861.
3. Flaatten H, Gjerde S, Guttormsen AB, et al. Outcome after acute respiratory failure is more dependent on dysfunction in other vital organs than on the severity of the respiratory failure. Crit Care. 2003;7:R72–R77.
4. Bersten AD, Edibam C, Hunt T, et al. Incidence and mortality of acute lung injury and the acute respiratory distress syndrome in three Australian states. Am J Respir Crit Care Med. 2002;165:443–448.
5. Mathay M. Acute Hypercapnic Respiratory Failure: Neuromuscular and Obstructive diseases. Chest Medicine: Essentials of Pulmonary and Critical Care Medicine. 3rd ed. Williams and Wilkins, Baltimore, Maryland; 1995:578–608.
6. Esteban A, Anzueto A, Frutos F, et al. Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. JAMA. 2002;287: 345–355.
7. Meduri GU, Turner RE, Abou-Shala N, et al. Noninvasive positive pressure ventilation via face mask: first-line intervention in patients with acute hypercapnic and hypoxemic respiratory failure. Chest. 1996;109:179–193.
8. Antonelli M, Conti G, Rocco M, et al. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med. 1998;339:429–435.
9. Delclaux C, L'Her E, Alberti C, et al. Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency with continuous positive airway pressure delivered by a face mask: a randomized controlled trial. JAMA. 2000;284:2352–2360.
10. West J, Wagner PD. Ventilation, Blood Flow, and Gas Exchange. Textbook of Respiratory Medicine. 3rd ed. Philadelphia: WB Saunders; 2000:55–90.
11. Hall JB, Schmidt GA, Wood LDH. Acute Hypoxemic Respiratory Failure. Textbook of Respiratory Medicine. 3rd ed. Philadelphia: WB Saunders; 2000:2413–2442.
12. Pierson DJ, Kacmarek RM. Respiratory failure: introduction and overview. In: Pierson DJ, ed. Foundations of Respiratory Care. New York: Churchill Livingstone; 1992:295–302.
13. Roussos C, Macklem PT. The respiratory muscles. N Engl J Med. 1982;307:786–797.
14. Roussos C, Koutsoukou A. Respiratory failure. Eur Respir J. 2003;47:3s–14s.
15. Grippi M. Respiratory Failure: An Overview. Fishman's Pulmonary diseases and Disorders. 4th ed. McGraw-Hill; New York, NY; 2008:2509–2521.
16. Schmidt GA, Hall JB, Wood LDH. Ventilatory Failure. Textbook of Respiratory Medicine. 3rd ed. Philadelphia: WB Saunders; 2000:2443–2470.
17. Claxton AR, Wong DT, Chung F, et al. Predictors of hospital mortality and mechanical ventilation in patients with cervical spinal cord injury. Can J Anaesth. 1998;45: 144–149.
18. Winslow C, Bode RK, Felton D, et al. Impact of respiratory complications on length of stay and hospital costs in acute cervical spine injury. Chest. 2002;121:1548–1554.
19. Berlly M, Shem K. Respiratory management during the first five days after spinal cord injury. J Spinal Cord Med. 2007;30:309–318.
20. Peterson WP, Barbalata L, Brooks CA, et al. The effect of tidal volumes on the time to wean persons with high tetraplegia from ventilators. Spinal Cord. 1999;37(4):284–288.
21. Chiodo AE, Scetza W, Forchheimer M. Predictors of ventilator weaning in individuals with high cervical spinal cord injury. J Spinal Cord Med. 2008;31:72–77.
22. Rabinstein AA, Wijdicks EF. Warning signs of imminent respiratory failure in neurological patients. Semin Neurol. 2003;23:97–103.
23. Hughes RA, Cornblath DR. Guillain–Barré syndrome. Lancet. 2005;366:1653–1666.
24. Ropper AH, Kehne SM. Guillain–Barré syndrome: management of respiratory failure. Neurology. 1985;35: 1662–1665.
25. Chevrolet JC, Deléamont P. Repeated vital capacity measurements as predictive parameters for mechanical ventilation need and weaning success in the Guillain–Barré syndrome. Am Rev Respir Dis. 1991;144:814–818.
26. Raphael JC, Masson C, Morice V, et al. The Landry–Guillain–Barré syndrome. Study of prognostic factors in 223 cases. Rev Neurol (Paris). 1986;142:613–624.
27. Ropper AH, Wijdicks EFM, Truax BT. Clinical Features of the Typical Syndrome, Guillain–Barré Syndrome. Philadelphia: FA Davis; 1991:73–105.
28. Orlikowski D, Terzi N, Blumen M, et al. Tongue weakness is associated with respiratory failure in patients with severe Guillain–Barré syndrome. Acta Neurol Scand. 2009;119:364–370.
29. Moore P, James O. Guillain–Barré syndrome: incidence, management and outcome of major complications. Crit Care Med. 1981;9:549–555.
30. Eisendrath SJ, Matthay MA, Dunkel J, et al. Guillain–Barré syndrome: psychosocial aspects of management. Psychosomatics. 1983;24:465–475.
31. JW Berkenbosch, RE Grueber, GR Graff, et al. Patterns of helium–oxygen (heliox) usage in the critical care environment. J Intensive Care Med. 2004;19(6): 335–344.